Google

Monday, March 31, 2008

Viagra Tips

Here are some tips on how to get the most out of your Viagra purchase.

  1. Make blood. Drink at least 1 gallon of water per day. This gives you blood volume, and it also helps you look and feel better. Viagra helps very much, but Viagra needs help too!
  2. Get firm. An erection alone is not enough. Get in better shape. Just a few things such as cutting back on bread, reducing portion size, and going for regular walks will help. Becoming very physically fit will help even more. Viagra in a fit body works better than Viagra in an unfit one. In fact, becoming very fit usually eliminates the need for Viagra in the first place.
  3. Make love all day. Your partner will respond better and thus raise your own excitement level, if you make a point of doing random acts of kindness throughout the day. A love note left in the refrigerator, a rose given for no special reason, engaging in real conversation for even a few minutes, and doing one of your partner's regular chores are all ways to say "You are special." Most guys can make big headway by leaving the toilet seat down. You may find you will need Viagra not because of impotence, but because your partner wants you several times a day.
  4. Make love to the whole person. This means showing you care--sort of like #3 above, but not just by acts of romance and thoughtfulness. You make love to the whole person by finding out what your lover really wants--and delivering.
  5. Make love to your partner's whole body. There's a lot of skin on the human body--make use of it.
  6. Don't rush into the bump and grind. Try kissing and caressing, warming your partner up to peak desire. Work at treating your partner as something other than a receptacle for your Viagra-charged tool.

These six tips can help you go from a Viagra-charged person who can do penetration to a dynamic lover who uses Viagra to help complete the job. There is much more to love-making and star-bursting satisfaction than Viagra can bring to the bedroom (or the kitchen table or wherever).

Use Viagra when you need to, but work on the other things, too.

Thursday, February 28, 2008

Viagra Matters

A new type of drug which increases blood flow to the vagina in animal experiments has now been shown to be safe in rats. Derived from an experimental heart drug, the new compounds could one day help treat women who find it difficult or impossible to become sexually aroused, say researchers at the drugs company Pfizer.

Previous tests have shown that the new compounds, including the most potent one, called R-13, increased vaginal blood flow in animals. New tests now demonstrate that the drugs are safely tolerated by rats.

The ultimate aim is to address female sexual arousal disorder (FSAD) in women. The condition sometimes involves blood flow problems in the pelvic region, which might be restored by a drug intervention.

Experts agree the approach might eventually benefit the small subset of women who suffer sexual dysfunction due to a physiological cause, due to nerve damage in the pelvic area from surgery, for example. But they stress that such drugs would not effectively treat FSAD when it is due to purely psychological factors.

In fact, some question the very existence of FSAD, adding that some women’s sexual dissatisfaction may have to do with the nature of the relationship the women are in

Sex differences

In the late 1990s, the approval of the drug sildenafil (Viagra) made by Pfizer, popularised the idea that men could be treated for erectile dysfunction with a simple pill. It became one of the pharmaceutical giant’s best-selling drugs.

Drug companies’ search for a compound to treat sexual dysfunction in women, however, are complicated by the fact that the disorder appears to have a wider number of causes in women, suggests Lori Brotto at the University of British Columbia in Vancouver, Canada.

Researchers at Pfizer derived the new compounds from a drug called Candoxatrilat, which was tested in clinical trials during the 1990s for treating chronic heart failure.

Tests show that a precursor of Candoxatrilat appears to disable a key enzyme called neutral endopeptidase, or NEP. This is important because NEP usually degrades a hormone called vasoactive intestinal peptide that promotes blood flow to the vagina. So blocking NEP may allow the hormone to maintain this blood flow.

"Too early"

The Pfizer group found that rats can tolerate NEP inhibitors derived from Candoxatrilat, such as a newly designed compound, R-13. New research carried out by the team also shows that R-13 rapidly inactivates NEP when ingested by laboratory animals. They add that previous experiments have suggested that R-13 can somewhat increase vaginal blood flow in rabbits.

“The objective of the research is to identify a rapid-acting, efficacious and well tolerated compound,” says Joel Morris, a spokesman for Pfizer in Sandwich, Kent, UK.

“A small subgroup of women might benefit from a biological approach,” says Brotto, who studies FSAD. But she adds that because there is such limited testing of the compound in animals, let alone humans, “it’s far too early to conclude anything” about the compound’s potential to treat sexual dysfunction in women.

Tuesday, February 26, 2008

Female Via

A new patch for women who have lost their sex drive will become available on the NHS this week.

Its makers say Intrinsa could be the female Viagra - the anti-impotence drug that has transformed the sex lives of hundreds of thousands of men.

The female aphrodisiac will initially only be available on prescription for post-menopausal women with diagnosed sexual problems. GPs will prescribe it on the NHS, with women paying a £6.65 prescription charge.

However it is likely that the patches will later become "lifestyle" drugs bought freely over the counter - used by younger women with no sexual problems who simply want to increase their libido.

The same thing happened with Viagra - around 60 per cent of the men who use it are believed to have no erectile problems. Around 900,000 men in Britain have used it at least once, estimates suggest.

The new treatment for women works by releasing the male hormone testosterone through the skin into the bloodstream.

The patch, which is virtually transparent and about the size of an egg, is worn just below the navel and changed twice weekly.

Manufacturers Procter and Gamble say the patch helped boost the flagging libido in hundreds of women in tests, and increased the amount of sexual activity they enjoyed.

Dramatically successful results were found in menopausal women who had been diagnosed with hypoactive sexual desire disorder, in which libido and sexual activity is reduced - leading to psychological distress.

More than 500 took part in the drug company's six-month study, with half unaware they had been given a dummy patch.

As well as boosting the amount of satisfying sex they had - making love four times more every two months than those wearing a dummy patch - it also increased desire.

Other tests shows it worked on women suffering loss of libido after a hysterectomy.

It was granted a license from the European Medicines Agency in July.

The Intrinsa patches work by increasing the level of testosterone in the blood. Although it is known as the male sex hormone, it is naturally occurring in women too, produced by the ovaries and the adrenal gland. However, levels of the hormone decline with age, sometimes dramatically so after the menopause.

Experts say a half of women having a hysterectomy and others having a premature menopause before the age of 50 could benefit from testosterone therapy.

However, too much testosterone can have unpleasant side-effects, from excessive body hair to liver disorders. That is why the makers went for a patch system rather than a pill, which would have led to too high a dose.

And the patch does not work straight away, unlike Viagra. It takes weeks to have an effect.

Intrinsa works on a completely different principle to Viagra. This is because while 90 per cent of male sexual problems are purely physical, women's sex problems are down to social, phsychological and emotional factors.

So unlike the mechanical problem that Viagra helps to fix in men, women's sexual functioning is about getting in the right frame of mind.

Procter and Gamble say the patches will help women with "female sexual dysfunction", a condition which was recognised only in 1999.

Some campaigners believe FSD is a syndrome invented by the pharmaceutical industry to medicalise the treatment of a social issue.

Many doctors believe that FSD covers at least four different conditions - problems with desire, arousal, achieving orgasm and genital pain - meaning it is unlikely one drug will be able to treat all four.